The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Cancer Research

• Publication date

  2007-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-07-0729PMID 17947460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein

  2007cited by this paper
• Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic.

  2007cited by this paper
• The case for survivin as a regulator of microtubule dynamics and cell-death decisions.

  2006cited by this paper
• Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP

  2006cited by this paper
• Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis

  2006cited by this paper
• Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

  2006cited by this paper
• Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.

  2006cited by this paper
• 6 INVITED Targeting the inhibitor of apoptosis (IAP) proteins

  2006cited by this paper
• The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells.

  2006cited by this paper
• The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases*

  2006cited by this paper
• Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic.

  2006cited by this paper
• Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas

  2005cited by this paper
• Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

  2005cited by this paper
• Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP

  2005cited by this paper
• Caspase activation: Stepping on the gas or releasing the brakes?

  2005cited by this paper
• Update on MALT lymphomas.

  2005cited by this paper
• XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs

  2005cited by this paper
• Survivin as a target for new anticancer interventions

  2005cited by this paper
• IAPs, RINGs and ubiquitylation

  2005cited by this paper
• Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.

  2005cited by this paper
• Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

  2005cited by this paper
• Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.

  2005cited by this paper
• Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice

  2004cited by this paper
• XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.

  2004cited by this paper
• Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

  2004cited by this paper
• A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death

  2004cited by this paper
• Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics

  2004cited by this paper
• Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

  2004cited by this paper
• Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.

  2004cited by this paper
• XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

  2004cited by this paper
• Targeting melanoma inhibitor of apoptosis protein with cancer immunotherapy

  2004cited by this paper
• The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.

  2004cited by this paper
• Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).

  2004cited by this paper
• X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells.

  2004cited by this paper
• Neutralization of Smac/Diablo by Inhibitors of Apoptosis (IAPs)

  2004cited by this paper
• An antisense oligonucleotide to cIAP‐1 sensitizes prostate cancer cells to fas and TNFα mediated apoptosis

  2004cited by this paper
• Validating survivin as a cancer therapeutic target

  2003cited by this paper
• Predominant Suppression of Apoptosome by Inhibitor of Apoptosis Protein in Non-Small Cell Lung Cancer H 460 Cells : Therapeutic Effect of a Novel Polyarginine-conjugated Smac Peptide

  2003cited by this paper
• Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis.

  2003cited by this paper
• Apoptosis-targeted therapies for cancer.

  2003cited by this paper
• Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction

  2003cited by this paper
• Mechanism of XIAP-mediated inhibition of caspase-9.

  2003cited by this paper
• Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.

  2003cited by this paper
• Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug‐resistant TCC in vitro

  2003cited by this paper
• Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.

  2003cited by this paper
• Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene

  2003cited by this paper
• Alterations in the apoptotic machinery and their potential role in anticancer drug resistance

  2003cited by this paper
• Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP).

  2003cited by this paper
• The inhibitors of apoptosis: there is more to life than Bcl2

  2003cited by this paper
• Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction.

  2003cited by this paper
• Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.

  2003cited by this paper
• Smac agonists sensitize for Apo 2 L / TRAILor anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

  2002cited by this paper
• Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis.

  2002cited by this paper
• IAP proteins: blocking the road to death's door

  2002cited by this paper
• Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma.

  2002cited by this paper
• Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy.

  2002cited by this paper
• IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition

  2002cited by this paper
• Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

  2002cited by this paper
• Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in Situ *

  2002cited by this paper
• SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP)*

  2002cited by this paper
• Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs

  2001cited by this paper
• XIAP: Apoptotic brake and promising therapeutic target

  2001cited by this paper
• Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis Proteins* * This work was supported by grants from the Canadian Institutes of Health Research (MOP-15691), the University of Ottawa-Industry Grants Program, and the Ottawa Civic Hospital Foundation.

  2001cited by this paper
• Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins.

  2001cited by this paper
• Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.

  2001cited by this paper
• XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.

  2001cited by this paper
• A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

  2001cited by this paper
• X-linked Inhibitor of Apoptosis Protein Functions as a Cofactor in Transforming Growth Factor-β Signaling*

  2001cited by this paper
• Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis.

  2001cited by this paper
• Detection of anti-livin antibody in gastrointestinal cancer patients.

  2001cited by this paper
• Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients.

  2001cited by this paper
• ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.

  2000cited by this paper
• Activation of NF-κB by XIAP, the X Chromosome-linked Inhibitor of Apoptosis, in Endothelial Cells Involves TAK1*

  2000cited by this paper
• Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.

  2000cited by this paper
• Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

  2000cited by this paper
• Structural basis of IAP recognition by Smac/DIABLO

  2000cited by this paper
• Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines.

  2000cited by this paper
• Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

  2000cited by this paper
• Structural and biochemical basis of apoptotic activation by Smac/DIABLO

  2000cited by this paper
• Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.

  2000cited by this paper
• Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.

  2000cited by this paper
• Biochemical pathways of caspase activation during apoptosis.

  1999cited by this paper
• Apoptosis control by death and decoy receptors.

  1999cited by this paper
• Endogenous Inhibitors of Caspases

  1999cited by this paper
• NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

  1998cited by this paper
• NF-k B Antiapoptosis : Induction of TRAF 1 and TRAF 2 and c-IAP 1 and c-IAP 2 to Suppress Caspase-8 Activation

  1998cited by this paper
• The CARD domain: a new apoptotic signalling motif.

  1997cited by this paper
• Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control.

  1997cited by this paper
• The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex.

  1996cited by this paper
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins.

  1995cited by this paper
• Mechanisms and genes of cellular suicide

  1995cited by this paper
• Translational Therapeutics

  year unknowncited by this paper

• Parthanatos and apoptosis: unraveling their roles in cancer cell death and therapy resistance

  2025cites this paper
• Peptide-modified nanoparticles for doxorubicin delivery: Strategies to overcome chemoresistance and perspectives on carbohydrate polymers.

  2025cites this paper
• BIRC3 RNA Editing Modulates Lipopolysaccharide-Induced Liver Inflammation: Potential Implications for Animal Health

  2025cites this paper
• CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA

  2024cites this paper
• MicroRNA‑24 alleviates colorectal cancer progression via a rs28382740 single nucleotide polymorphism in the long noncoding region of X‑linked inhibitor of apoptosis protein

  2024cites this paper
• Anticancer mechanism of coumarin-based derivatives.

  2024cites this paper
• Multifaceted Evaluation of Inhibitors of Anti-Apoptotic Proteins in Head and Neck Cancer: Insights from In Vitro, In Vivo, and Clinical Studies (Review)

  2024cites this paper
• Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions

  2024cites this paper
• iSCAN: Identifying Causal Mechanism Shifts among Nonlinear Additive Noise Models

  2023cites this paper
• Prostate cancer and microRNAs: New insights into apoptosis.

  2023cites this paper
• Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.

  2023cites this paper
• Model‐Informed Selection of the Recommended Phase III Dose of the Inhibitor of Apoptosis Protein Inhibitor, Xevinapant, in Combination with Cisplatin and Concurrent Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

  2023cites this paper
• Targeting multifunctional magnetic nanowires for drug delivery in cancer cell death: an emerging paradigm

  2023cites this paper
• Protein and Peptide-based Nanoparticles as an emerging strategy to tackle cancer drug resistance

  2023cites this paper
• Simultaneous XIAP and cIAP1/2 inhibition by a dimeric SMAC mimetic AZD5582 induces apoptosis in multiple myeloma.

  2023cites this paper
• MicroRNAs regulate inhibitor of apoptosis proteins (IAPs) in colorectal cancer.

  2023cites this paper
• Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck

  2022cites this paper
• Autoimmune diseases and apoptosis: Targets, challenges, and innovations

  2021cites this paper
• A novel ferrocene-palladium metal complex: synthesis, single crystal structure, in vitro cytotoxicity study and molecular docking

  2021cites this paper
• Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas

  2021cites this paper
• MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells

  2021cites this paper
• CHEMICAL INVESTIGATION AND ANTIPROLIFERATIVE STUDIES OF ISOLATED POLYISOPRENYLATED BENZOPHENONES FROM STEM-BARK OF Garcinia maingayi

  2021cites this paper
• Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances

  2021cites this paper
• Increased migration and motility in XIAP-null cells mediated by the C-RAF protein kinase

  2021cites this paper
• ULK1 and ULK2 are less redundant than previously thought: computational analysis uncovers distinct regulation and functions of these autophagy induction proteins

  2020cites this paper
• Apoptosis (programmed cell death) and its signals - A review.

  2020cites this paper
• Molecular dynamics simulation revealed the intrinsic conformational change of cellular inhibitor of apoptosis protein-1

  2020cites this paper
• Sensitization of pancreatic carcinoma cells for chemotherapy-induced apoptosis using small-molecule inhibitors of X-linked inhibitor of apoptosis protein (XIAP)

  2020cites this paper
• Diacetoxy iodobenzene mediated regioselective synthesis and characterization of novel [1,2,4]triazolo[4,3-a]pyrimidines: apoptosis inducer, antiproliferative activities and molecular docking studies

  2020cites this paper
• Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy.

  2020cites this paper
• Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer Cells

  2019cites this paper
• Position of lipidation influences anticancer activity of Smac analogs.

  2019cites this paper
• Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling

  2019cites this paper
• Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade

  2019cites this paper
• iTRAQ-based quantitative proteomics analysis of the spleen reveals innate immunity and cell death pathways associated with heat stress in broilers (Gallus gallus).

  2019cites this paper
• Regulation of Protein Activity and Cellular Functions Mediated by Molecularly Evolved Nucleic Acids.

  2019cites this paper
• Apoptosis in Cancer Cell Signaling and Current Therapeutic Possibilities

  2019cites this paper
• Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives.

  2019cites this paper
• Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach.

  2018cites this paper
• Leishmania donovani induced Unfolded Protein Response delays host cell apoptosis in PERK dependent manner

  2018cites this paper
• Journal of Reproduction and Development

  2018cites this paper
• The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma

  2018cites this paper
• Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancer

  2018cites this paper
• Les inhibiteurs de l'apoptose, une nouvelle cible thérapeutique dans les glioblastomes

  2017cites this paper
• Investigating isoquinoline derivatives for inhibition of inhibitor of apoptosis proteins for ovarian cancer treatment

  2017cites this paper
• Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack

  2017cites this paper
• Inhibition of IAP’s and activation of p53 leads to caspase-dependent apoptosis in gastric cancer cells treated with Scutellarein

  2017cites this paper
• BRUCE Protein, New Marker for Targeted Therapy of Gastric Carcinoma

  2017cites this paper
• Expression analysis of BRUCE protein in esophageal squamous cell carcinoma.

  2016cites this paper
• Semiparametric Differential Graph Models

  2016cites this paper
• Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes

  2016cites this paper
• Investigating the role of a novel Type IV secretion system in Legionella pneumophila

  2016cites this paper
• Anticancer activity of ceratotheca triloba

  2016cites this paper
• Characterization of TRAIL-mediated apoptotic pathways in the lung cancer cell line NCI-H460 with focus on caspase-3 and XIAP

  2016cites this paper
• Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation

  2016cites this paper
• miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.

  2016cites this paper
• Anti-Angiogenic and Anti-Cancer Effects by Targeting the Protein Kinase G Type-Iα (PKG-Iα) Signaling Pathway and its Downstream Effects on Expression of Inhibitor of Apoptosis Proteins, C-IAP1, Livin and Survivin

  2016cites this paper
• Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy

  2016cites this paper
• Apoptosis-Biochemistry: A Mini Review

  2015cites this paper
• A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer

  2015cites this paper
• GDC-0152 attenuates the malignant progression of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK signaling pathway.

  2015cites this paper
• Mechanisms of apoptosis in ovarian cancer: The small molecule targeting

  2015cites this paper
• Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA.

  2015cites this paper
• IAP antagonization promotes inflammatory destruction of vasculature endothelium and inhibits tumor growth

  2015cites this paper
• Apoptosis and cancer: insights molecular mechanisms and treatments

  2015cites this paper
• miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB

  2015cites this paper
• Modulation der Apoptose in Raw 264.7 und Thp-1 Makrophagen durch Infektion mit Leishmania major

  2015cites this paper
• Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.

  2015cites this paper
• Lipid-conjugated Smac analogues.

  2015cites this paper
• Small molecule inhibitor of apoptosis proteins antagonists: a patent review

  2015cites this paper
• HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization

  2014cites this paper
• Potent and Selective Small-Molecule Inhibitors of cIAP1/2 Proteins Reveal That the Binding of Smac Mimetics to XIAP BIR3 Is Not Required for Their Effective Induction of Cell Death in Tumor Cells

  2014cites this paper
• Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents.

  2014cites this paper
• Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials.

  2014cites this paper
• Direct estimation of differential networks.

  2014cites this paper
• Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin

  2014cites this paper
• IAP family of cell death and signaling regulators.

  2014cites this paper
• Soluble‐E‐cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers

  2014cites this paper
• APOPTOSIS (PROGRAMMED CELL DEATH) - A REVIEW

  2014cites this paper
• The prognostic significance of clinicopathological features and apoptosis inhibitor proteins in pancreas ductal adenocarcinoma.

  2014cites this paper
• Dynamic activation of apoptosis: conformational ensembles of cIAP1 are linked to a spring-loaded mechanism

  2014cites this paper
• Novel dimeric Smac analogs as prospective anticancer agents.

  2014cites this paper
• Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer

  2014cites this paper
• A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cells

  2014cites this paper
• IAP Proteins and Their Therapeutic Potential

  2014cites this paper
• Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients

  2013cites this paper
• CITOTOKSIČNO DEJSTVO EKSTRAKATA BILJKE SIDERITIS SCARDICA NA TUMORSKE ĆELIJE U IN VITRO USLOVIMA

  2013cites this paper
• Bioactive Rosette Nanotubes for Bone Tissue Engineering and Drug Delivery

  2013cites this paper
• Zinc sensitizes prostate cancer cells to sorafenib and regulates the expression of Livin.

  2013cites this paper
• Antagonists of IAP proteins as cancer therapeutics.

  2013cites this paper
• Evaluation of Metabolism and Disposition of GDC-0152 in Rats Using 14C Labeling Strategy at Two Different Positions: A Novel Formation of Hippuric Acid from 4-Phenyl-5-Amino-1,2,3-Thiadiazole

  2013cites this paper
• Integrating immune cell functions and apoptosis-based therapies for the treatment of ovarian cancer

  2013cites this paper
• Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy

  2013cites this paper
• A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice.

  2013cites this paper
• Telomerase and Caspase 3 Expression of Colon Ephitelial Cells Hyperplasia After Andrographis paniculata Nees Extract Administration

  2013cites this paper
• Pengaruh Polifenol Mahkota Dewa terhadap Proliferasi Sel dan Apoptosis pada Mencit Strain Balb/C yang Diinduksi Benzo(a) Pyrene (BaP)

  2013cites this paper
• Drug Resistance and Molecular Cancer Therapy: Apoptosis Versus Autophagy

  2013cites this paper
• Cell Toxicity Evaluation of Lipid-based Nanoparticles delivering Survivin-siRNA and Doxil in Sensitive and Resistant Human Carcinoma

  2013cites this paper
• Dendritic Cells for Cancer Immunotherapy

  2013cites this paper
• Targeted silencing of inhibitors of apoptosis proteins with siRNAs: a potential anti-cancer strategy for hepatocellular carcinoma.

  2013cites this paper